In this episode, Jewel Mullen, MD, MPH, MPA, FACP, discusses strategies for implementing RSV vaccines into practice, with an emphasis on: Understanding the reasoning for Advisory Committee on Immunization Practices RSV vaccine recommendations Factors that influence vaccine uptake and patient decision-making Considerations for patient and healthcare professional vaccine hesitancy Building vaccine confidence in both patients and healthcare professionals Using shared decision-making models (eg, SHA...
May 07, 2024•12 min•Ep. 385
In this episode, Angela Branche, MD, FIDSA, explores the burden of RSV disease in older adults, including: RSV seasonality and disease burden Symptoms and complications of RSV infection Older age as a key risk factor for severe RSV disease and complications (eg, pneumonia, hospitalization) Comorbidities associated with increased risk of RSV hospitalization RSV hospitalization rates among different racial and ethnic minority groups and socioeconomic statuses Faculty: Angela Branche, MD, FIDSA Ass...
May 07, 2024•14 min•Ep. 386
Using common case scenarios, Robert H. Hopkins, Jr., MD, MACP, and Laura P. Hurley, MD, MPH, discuss strategies for optimizing shingles vaccine uptake, including: The pathophysiology of shingles to better understand risk and burden CDC guidelines and ACIP shingles vaccine recommendations, including considerations for those who are immunocompromised Strategies for optimizing shingles vaccine uptake no matter the clinical setting How to address shingles vaccine‒related adverse events Addressing in...
Apr 30, 2024•48 min•Ep. 384
In this episode, Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, and Nimish Patel, PharmD, PhD, AAHIVP, cover the most impactful clinical studies presented at CROI 2024, including: New data on long-acting ART, including: The CARES study of LA CAB + RPV in a sub-Saharan African population using a public health approach The IMPAACT 2017 MOCHA study evaluating switching to LA CAB + RPV in adolescents living with HIV The ACTG A5359 LATITUDE study of LA CAB + RPV in people with adherence challenges to...
Apr 29, 2024•28 min•Ep. 383
In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to: Engage key stakeholders in the provision of HBV care Provide HBV management resources to support PCPs who are doing screening Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBV Presenters: Su Wang, MD, MPH, FACP Medical Director Center for Asian Health and Viral He...
Apr 26, 2024•19 min•Ep. 382
In this episode, Gregory Huhn, MD, MPHTM, uses a case study to explore the reasons healthcare professionals and people living with HIV may want to further optimize ART in the setting of viral suppression. To determine the best outcome for this case study, Dr Huhn discusses the reasons individuals may not be satisfied with daily oral ART and examines data to suggest that, for some individuals with virologic suppression, switching to long-acting ART may address internalized HIV stigma. Finally, Dr...
Apr 11, 2024•12 min•Ep. 381
In this episode, Maria Buti, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Barriers to HBV screening, including patient- and provider-specific barriers (eg, lack of education, failure to disclose or discuss risk factors, perceived low risk, stigma) Applying CDC recommendations for universal HBV screening in adults Strategies to improve HBV transitions of care (eg, improved education, simplify criteria for screening and monit...
Apr 10, 2024•17 min•Ep. 380
In this episode, Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the key HIV studies from CROI 2024 that are influencing their clinical practice, including: New data surrounding long-acting ART, including: The CARES study of LA CAB + RPV in a Sub-Saharan African population using a public health approach The IMPAACT 2017 MOCHA study evaluating switching to LA CAB + RPV in adolescents living with HIV The ACTG A5359 LATITUDE study of LA CAB + RPV in people with adherence challenges to ...
Mar 29, 2024•44 min•Ep. 379
In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness considerations Integration of patient perspectives in wider treatment Presenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Director, D...
Mar 26, 2024•21 min•Ep. 378
In this episode, Robert Wong, MD, MS, and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Opportunities to improve patient education, including education for expectant mothers with HBV Potential cultural considerations that may result in delayed HBV diagnosis and care Stigma reduction with universal HBV screening and vaccination Strategies to improve patient education (eg, online resources, advocacy groups, use of layman’s terms and dia...
Mar 11, 2024•17 min•Ep. 377
Listen to Roger Bedimo, MD, MS, FACP, discuss considerations for older people living with HIV, including: Polypharmacy and deprescribing The risk of cardiovascular events with various ART regimens Approaches for managing weight gain Presenter: Roger Bedimo, MD, MS, FACP Professor of Medicine Interim Director, Office of Global Health UT Southwestern Medical Center Chief, Infectious Diseases Section VA North Texas Health Care System Dallas, Texas Get access to all of our new podcasts by subscribin...
Mar 08, 2024•15 min•Ep. 376
In this episode, Dr. Bedimo discusses best practices for individualized care in transgender women living with HIV, including: Providing services in a gender-affirmative care model Proactive counseling on drug-drug interactions with gender-affirming hormone therapy Strategies to reduce adverse events Presenter: Roger Bedimo, MD, MS, FACP Professor of Medicine Interim Director, Office of Global Health UT Southwestern Medical Center Chief, Infectious Diseases Section VA North Texas Health Care Syst...
Mar 04, 2024•12 min•Ep. 375
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss how to optimize the use of COVID-19 antivirals and how to navigate drug-drug interactions between COVID-19 treatments and a patient’s home medications. Their discussion includes: Current COVID-19 landscape COVID-19 testing and vaccination recommendations Treatment guidelines and antiviral options for nonhospitalized adults with COVID-19 Resources for assessing and managing COVID-19 antiviral-related drug-drug interactio...
Feb 27, 2024•34 min•Ep. 374
In this episode, Nancy Reau, MD, discusses new data on hepatitis B virus presented at AASLD 2023, including: Current therapies Studies 108 and 110: Factors Linked With Lack of Virologic Suppression After 8 Yr of TAF or TDF Kaiser Permanente Northern California: HCC or Death With TDF vs ETV for Chronic Hepatitis B Early vs Late Postpartum Cessation of TDF Initiated for Prevention of Vertical HBV Transmission Investigational functional cure strategies B-Together: Sequential Bepirovirsen and PegIFN...
Feb 05, 2024•37 min•Ep. 373
In this episode, LaRon E. Nelson, PhD, RN, FNP, FNAP, FNYAM, FAAN, discusses the role that healthcare professionals (HCPs) may be playing in their patients’ pre-exposure prophylaxis (PrEP) persistence and strategies to modify their approach to encourage persistence, from Clinical Care Options (CCO), including: Racial disparities in the PrEP care continuum Consideration that PrEP persistence may be less about relationship to the drug than the environment Examples of HCP implicit bias regarding Pr...
Jan 31, 2024•27 min•Ep. 372
In this episode, Nancy Reau, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus and hepatitis delta virus, including: The importance of patient education along the care continuum Ensuring smooth transitions of care and communication between medical teams Screening hepatitis delta in persons with chronic hepatitis B Managing hepatitis delta, including considerations for clinical trials Promoting patient advocacy Presenter: Nancy Reau, MD Professor ...
Jan 24, 2024•15 min•Ep. 371
In this episode, David Saunders discusses the value of nonstigmatizing discussions between people using HIV pre-exposure prophylaxis (PrEP) and healthcare professionals, including: Encouraging accountability to individualize adherence strategies and improve persistence to PrEP Reducing stigma, discrimination, and prejudice in healthcare settings to foster PrEP persistence Faculty: David Saunders PrEP User and Advocate Link to full program: https://bit.ly/3ZlICsL To automatically get new episodes...
Jan 12, 2024•6 min•Ep. 370
In this episode, Sarah M. Wood, MD, MS, discusses data and recommendations for long-acting pre-exposure prophylaxis (PrEP) as a strategy to support PrEP persistence and engagement for adolescents, including: The PrEP care continuum for adolescents System barriers to PrEP coverage and privacy concerns for adolescents The benefits and challenges of same-day PrEP initiation and real-world data to support it Interventions to support PrEP persistence PrEP options for different populations and the dat...
Jan 10, 2024•30 min•Ep. 369
In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including: Current Advisory Committee on Immunization Practices recommendations Risk factors associated with severe RSV disease, including RSV-related hospitalizations Approach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities Health disparities relate...
Dec 27, 2023•10 min•Ep. 368
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screening for HBV Addressing patient-, provider-, and system-level barriers to universal HBV screening Best practices for implementation of HDV screening Pr...
Dec 22, 2023•28 min•Ep. 367
In this episode, Tavell L. Kindall, PhD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP, and Anne Teitelman, PhD, FNP-BC, FANNP, FAAN, discuss key PrEP considerations for advanced practice providers in primary care settings, including: The importance of having PrEP navigators to help with logistics and be a point of contact for patients Where to find education and resources to familiarize yourself with PrEP and its prescribing Safety considerations and adverse events associated with PrEP options PrEP c...
Dec 21, 2023•28 min•Ep. 366
In this podcast episode, Mark Brennan-Ing, PhD, and Nina I. Martinez discuss mental health challenges in people living with HIV and much-needed strategies to overcome these challenges to optimize engagement in HIV care, including: The increased rates of mental health disorders and substance use among people living with HIV How mental health disorders contribute to challenges with adherence to HIV treatment and engagement in care How social isolation and stigma can affect outcomes despite access ...
Dec 20, 2023•44 min•Ep. 365
In this podcast episode, Isolde Butler, MD, MPH, a healthcare professional caring for people living with HIV, and Marissa Gonzalez, an individual living with HIV, discuss strategies to improve healthcare professionals’ competencies in delivering optimal HIV care from the start to better support patients in overcoming barriers to sustained care engagement. The topics they discuss include: An introduction to the guidelines on ART initiation—start quickly and choose the therapy that is effective an...
Dec 18, 2023•42 min•Ep. 364
In this podcast episode, Babafemi Taiwo, MBBS, and Vincent Crisostomo discuss the evolving treatment landscape for aging people living with HIV, encompassing the clinical and external resources necessary to support physical and psychosocial health. The topics discussed include: • Mindful prescribing and understanding the impact an HIV diagnosis can have on one’s mental health, including social isolation • How to address patients’ needs and establish a trusting relationship within the confines of...
Dec 18, 2023•30 min•Ep. 363
In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including: Postexposure prophylaxis (PEP) recommendations and the data for PEP-in-Pocket Offering PrEP to everyone who receives PEP Currently recommended PrEP options and the safety and adverse event considerations with each option Monitoring recommendations for the different PrEP options The importance...
Dec 15, 2023•16 min•Ep. 362
During the 2023 American Association for the Study of Liver Diseases conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-δ agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and a fibrate. In this episode, Kris V. Kowdley MD, FAASLD, FACP, FACG, discusses topline results from several of these studies and more, including: A com...
Dec 13, 2023•18 min•Ep. 361
In this episode, Dr Tavell Kindall and Jona Tanguay discuss actionable strategies for advanced practice providers to increase the frequency at which PrEP is offered and initiated in primary care settings. Topics covered include: Available training resources on how to offer PrEP in primary care Affordable, accessible PrEP options, including patient assistance programs Using electronic health records to identify candidates for PrEP Opportunities to offer PrEP during appointments regarding birth co...
Dec 12, 2023•25 min•Ep. 360
In this third of 3 episodes, global HIV experts and advocates discuss the current status of HIV cure research, including key concepts to understand and communicate when counselling patients, colleagues, and the broader community on HIV cure: Latest understanding of the viral reservoir New insights and questions on the best timing for cure interventions Current investigational strategies showing promise Ethical considerations related to participant education, representation in clinical trials, an...
Dec 11, 2023•53 min•Ep. 355
In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including: Burden of CRE infections in the United States Mechanisms of resistance Changing epidemiology Use of rapid diagnostic tests IDSA guidance recommendations, including supporting data Approach to designing treatment regimens, including weighing patient- and infection-related factors Faculty: Julie Ann Justo, PharmD, MS, FIDSA, BCPS Clinical Pharmacist L...
Dec 07, 2023•16 min•Ep. 357
In this episode, Errol L. Fields, MD, PhD, MPH, and Armonté Butler, MPH, a pre-exposure prophylaxis (PrEP) advocate, discuss strategies for overcoming barriers to uptake of PrEP for HIV in adolescents and young adults, based on the unique needs of this patient population. Topics covered include: Methods for building trust between patients and providers Ways to practice shared decision-making and how this process hinges on respecting patients’ autonomy and personhood How to empower young people t...
Dec 07, 2023•20 min•Ep. 358
